IQV Q4 2024 Earnings — IQVIA Holdings Inc. Revenue & Financial Results | Market Cap Arena

IQVIQVIA Holdings Inc.

$30B

Q4 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$4.0B+2.3% YoY

Gross Profit

$1.4B34.8% margin

Operating Income

$626M15.8% margin

Net Income

$437M11.0% margin

EPS (Diluted)

$2.42

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

$885M

Free Cash Flow

$721M

Stock-Based Comp.

$48M

Balance Sheet

Total Assets

$26.9B

Total Liabilities

$20.8B

Stockholders' Equity

$6.1B

Cash & Equivalents

$1.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.0B	$3.9B	+2.3%
Gross Profit	$1.4B	$1.4B	-0.9%
Operating Income	$626M	$501M	+25.0%
Net Income	$437M	$469M	-6.8%

Revenue Segments

Research And Development Solutions

$2.1B54%

Technology And Analytics Solutions

$1.7B42%

Contract Sales And Medical Solutions

$177M4%

Geographic Segments

Americas

$1.9B47%

EMEA

$1.3B33%

Asia Pacific

$807M20%